Clinical Trial Update: Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a stereotactic boost/treatment for recurrent or metastatic head and neck cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Recurrent Head and Neck Carcinoma, Head and Neck Cancer Metastatic | Phase 1 | Status: ACTIVE_NOT_RECRUITING